Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

APRE

Aprea Therapeutics (APRE)

Aprea Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:APRE
DateTimeSourceHeadlineSymbolCompany
14/05/202422:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
14/05/202422:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APREAprea Therapeutics Inc
07/02/202409:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
05/02/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:APREAprea Therapeutics Inc
03/02/202408:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
26/01/202423:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
26/01/202422:03Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:APREAprea Therapeutics Inc
05/01/202408:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
10/11/202308:20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:APREAprea Therapeutics Inc
10/11/202308:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
10/11/202308:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APREAprea Therapeutics Inc
17/10/202308:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
13/10/202322:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
11/09/202322:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
25/08/202311:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APREAprea Therapeutics Inc
25/08/202311:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APREAprea Therapeutics Inc
25/08/202311:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APREAprea Therapeutics Inc
24/08/202322:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
10/08/202321:39Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APREAprea Therapeutics Inc
10/08/202321:36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
11/07/202321:40Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:APREAprea Therapeutics Inc
11/07/202321:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:APREAprea Therapeutics Inc
06/07/202306:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
14/06/202322:00GlobeNewswire Inc.Aprea Therapeutics to Present at Maxim Virtual Healthcare ConferenceNASDAQ:APREAprea Therapeutics Inc
09/06/202306:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APREAprea Therapeutics Inc
30/05/202322:30GlobeNewswire Inc.Aprea Therapeutics to Present at BIO International ConventionNASDAQ:APREAprea Therapeutics Inc
16/05/202306:48Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APREAprea Therapeutics Inc
16/05/202306:40Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APREAprea Therapeutics Inc
16/05/202306:05GlobeNewswire Inc.Aprea Therapeutics Reports First Quarter 2023 Financial Results and Provides Update on Business OperationsNASDAQ:APREAprea Therapeutics Inc
09/05/202307:16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APREAprea Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:APRE